Silence Therapeutics earnings were -$76.4M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest SLN earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$35.5M, up 80.4% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, SLN reported annual earnings of -$54.8M, with 12.3% growth.
Silence Therapeutics Earnings Reports & History FAQ
What were Silence Therapeutics's earnings last quarter?
Silence Therapeutics (NASDAQ: SLN) reported Q3 2024 earnings per share (EPS) of N/A, up N/A year over year. Total SLN earnings for the quarter were -$35.54 million. In the same quarter last year, Silence Therapeutics's earnings per share (EPS) was N/A.
Is Silence Therapeutics profitable or losing money?
As of the last Silence Therapeutics earnings report, Silence Therapeutics is currently losing money. Silence Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$77.45 million, a 50.84% increase year over year.
What was SLN's earnings growth in the past year?
As of Silence Therapeutics's earnings date in Q1 2025, Silence Therapeutics's earnings has grown year over year. SLN earnings in the past year totalled -$76.44 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.